About Urokinase-type plasminogen activator
Urokinase-type plasminogen activator (PLAU) is a protein
from Homo sapiens identified by UniProt accession
P00749, 431 residues long.
MolForge cross-references it against 0 known binders and
617 disease associations.
Target properties
| Protein name | Urokinase-type plasminogen activator |
| UniProt accession | P00749 |
| Gene | PLAU |
| Organism | Homo sapiens |
| Length | 431 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (7)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (617)
Diseases linked to this target (Open Targets).
- Quebec platelet disorder · score 0.66
- blood protein measurement · score 0.42
- pulmonary embolism · score 0.39
- coronary artery disease · score 0.38
- myocardial infarction · score 0.37
- subarachnoid hemorrhage · score 0.37
- Recurrent thrombophlebitis · score 0.37
- Crohn's disease · score 0.35
- inflammatory bowel disease · score 0.34
- stroke · score 0.33
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P00749-F1 | alphafold | PREDICTED | 82.12 | — |
Amino-acid sequence (431 residues)
MRALLARLLL CVLVVSDSKG SNELHQVPSN CDCLNGGTCV SNKYFSNIHW CNCPKKFGGQ HCEIDKSKTC YEGNGHFYRG KASTDTMGRP CLPWNSATVL QQTYHAHRSD ALQLGLGKHN YCRNPDNRRR PWCYVQVGLK LLVQECMVHD CADGKKPSSP PEELKFQCGQ KTLRPRFKII GGEFTTIENQ PWFAAIYRRH RGGSVTYVCG GSLISPCWVI SATHCFIDYP KKEDYIVYLG RSRLNSNTQG EMKFEVENLI LHKDYSADTL AHHNDIALLK IRSKEGRCAQ PSRTIQTICL PSMYNDPQFG TSCEITGFGK ENSTDYLYPE QLKMTVVKLI SHRECQQPHY YGSEVTTKML CAADPQWKTD SCQGDSGGPL VCSLQGRMTL TGIVSWGRGC ALKDKPGVYT RVSHFLPWIR SHTKEENGLA L
Explore Urokinase-type plasminogen activator with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets